Scientists discover new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.
The findings, which were published this week online ahead of print by the journal emCancer/em, focus on a protein called Choline phosphate cytidylyltransferase-a CCT-a or CCTa, an "antigen" that prompts ...
Scientists discover new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.
The findings, which were published this week online ahead of print by the journal emCancer/em, focus on a protein called Choline phosphate cytidylyltransferase-a CCT-a or CCTa, an "antigen" that prompts ...